# Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age

> **NCT01365481** · PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 150 (actual)

## Conditions studied

- Hypertension
- Chronic Kidney Disease

## Interventions

- **DRUG:** Valsartan
- **DRUG:** amlodipine
- **DRUG:** Hydrochlorothiazide

## Key facts

- **NCT ID:** NCT01365481
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2016-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01365481

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01365481, "Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01365481. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*